Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer

被引:23
作者
Liu, Shuyu [1 ]
Yang, Xilan [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 4, Dept Gen Practice, Nanjing, Peoples R China
关键词
intestinal flora; bacterial translocation; dysbiosis; hepatitis; cirrhosis; liver cancer; GUT MICROBIOTA; RECEPTOR; 4; HEPATOCELLULAR-CARCINOMA; PATHOGEN RECOGNITION; IMMUNE-RESPONSE; TH17; CELLS; T-CELLS; PROLIFERATION; TUMORIGENESIS; ACTIVATION;
D O I
10.3389/fcimb.2023.1140126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The liver is a vital metabolism and detoxification organ of human body, which is involved in the biotransformation and metabolism of the organism. Hepatitis - cirrhosis - liver cancer are significant and common part of liver diseases. The pathogenesis of liver diseases is generally as followed: inflammation and other pathogenic factors cause persistent damage to the liver, leading to the activation of hepatic stellate cells (HSCs) and excessive deposition of extracellular matrix. Patients with chronic hepatitis have a high risk of developing into liver fibrosis, cirrhosis, and even life-threatening liver cancer, which poses a great threat to public health.As the first organ to come into contact with blood from the gut, the liver is profoundly affected by the intestinal flora and its metabolites, with leaky gut and flora imbalance being the triggers of the liver's pathological response. So far, no one has reviewed the role of intestinal flora in this process from the perspective of the progression of hepatitis-cirrhosis-liver cancer and this article reviews the evidence supporting the effect of intestinal flora in the progression of liver disease.
引用
收藏
页数:12
相关论文
共 111 条
[1]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[2]   Role of gut microbiota in liver disease [J].
Albhaisi, Somaya A. M. ;
Bajaj, Jasmohan S. ;
Sanyal, Arun J. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2020, 318 (01) :G84-G98
[3]   Gut microbiome alterations in patients with stage 4 hepatitis C [J].
Aly, AbdelRahman Mahmoud ;
Adel, AbdelReheem ;
El-Gendy, Ahmed Osama ;
Essam, Tamer M. ;
Aziz, Ramy K. .
GUT PATHOGENS, 2016, 8
[4]   Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation [J].
Bajaj, Jasmohan S. ;
Hylemon, Phillip B. ;
Ridlon, Jason M. ;
Heuman, Douglas M. ;
Daita, Kalyani ;
White, Melanie B. ;
Monteith, Pamela ;
Noble, Nicole A. ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 303 (06) :G675-G685
[5]   Linkage of gut microbiome with cognition in hepatic encephalopathy [J].
Bajaj, Jasmohan S. ;
Ridlon, Jason M. ;
Hylemon, Phillip B. ;
Thacker, Leroy R. ;
Heuman, Douglas M. ;
Smith, Sean ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 302 (01) :G168-G175
[6]   Direct Stimulation of tlr5+/+ CD11c+ Cells Is Necessary for the Adjuvant Activity of Flagellin [J].
Bates, John T. ;
Uematsu, Satoshi ;
Akira, Shizuo ;
Mizel, Steven B. .
JOURNAL OF IMMUNOLOGY, 2009, 182 (12) :7539-7547
[7]   C-Type Lectin Receptors in Antiviral Immunity and Viral Escape [J].
Bermejo-Jambrina, Marta ;
Eder, Julia ;
Helgers, Leanne C. ;
Hertoghs, Nina ;
Nijmeijer, Bernadien M. ;
Stunnenberg, Melissa ;
Geijtenbeek, Teunis B. H. .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[8]   Translation of immunological knowledge into better treatments of chronic hepatitis B [J].
Bertoletti, A ;
Naoumov, NV .
JOURNAL OF HEPATOLOGY, 2003, 39 (01) :115-124
[9]   The Bacteroides fragilis Toxin Gene Is Prevalent in the Colon Mucosa of Colorectal Cancer Patients [J].
Boleij, Annemarie ;
Hechenbleikner, Elizabeth M. ;
Goodwin, Andrew C. ;
Badani, Ruchi ;
Stein, Ellen M. ;
Lazarev, Mark G. ;
Ellis, Brandon ;
Carroll, Karen C. ;
Albesiano, Emilia ;
Wick, Elizabeth C. ;
Platz, Elizabeth A. ;
Pardoll, Drew M. ;
Sears, Cynthia L. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) :208-215
[10]  
Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]